Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

6.7%

6 terminated out of 90 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

7%

6 trials in Phase 3/4

Results Transparency

9%

3 of 33 completed with results

Key Signals

3 with results85% success

Data Visualizations

Phase Distribution

65Total
Not Applicable (49)
Early P 1 (2)
P 1 (6)
P 2 (2)
P 3 (4)
P 4 (2)

Trial Status

Completed33
Unknown28
Recruiting12
Not Yet Recruiting7
Terminated6
Active Not Recruiting1

Trial Success Rate

84.6%

Benchmark: 86.6%

Based on 33 completed trials

Clinical Trials (90)

Showing 20 of 20 trials
NCT06632418Phase 2CompletedPrimary

Evaluating an rhPDGF-BB-enhanced Collagen Plug for Perianal Fistula Healing

NCT05243966Recruiting

Myriad™ Augmented Soft Tissue Reconstruction Registry

NCT07704359Phase 4Not Yet Recruiting

Antibiotics After Incision and Drainage to Prevent Fistula Formation After First Episode of Perianal Abscess

NCT07681531Not ApplicableNot Yet Recruiting

Laser Ablation Versus Conventional Fistulectomy for Uncomplicated Perianal Fistula

NCT05974280Recruiting

Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells

NCT07579715Not ApplicableCompletedPrimary

Comparison Of Surgical Outcomes Between Ligation Of Intersphincteric Fistula Tract And Fistulotomy With Seton In Perianal Fistula

NCT04073472Phase 1Withdrawn

Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's

NCT07477496Recruiting

Recurrence and Anal Fistula Patient Reported Outcomes Trial

NCT07482241Not Yet Recruiting

Impact of Surgical Timing on Anal Fistula Outcomes

NCT07323160Not ApplicableNot Yet RecruitingPrimary

Determining the Effect of Education Given to Patients Undergoing Outpatient Anal Fistula Surgery

NCT04190862Phase 1RecruitingPrimary

E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

NCT05641844Not ApplicableRecruitingPrimary

A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas

NCT05933343Not ApplicableTerminatedPrimary

Ethibond Suture vs Vessel Loop as Draining Seton for Complex Anal Fistulas

NCT03865823Active Not RecruitingPrimary

Evaluation of the Recovery Rate and Postoperative Incontinence of Surgical Fistulas in a Cohort of a Reference Centre

NCT07128953Early Phase 1Enrolling By InvitationPrimary

Study on the Mechanism of Zuoqing San Promoting Postoperative Wound Healing of Anal Fistula by Inhibiting ROS-dependent NETosis

NCT07102134Not ApplicableCompleted

The Modified Clipped-LIFT Procedure for High Transsphincteric or Suprasphincteric Fistula

NCT07081373Not ApplicableRecruitingPrimary

Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.

NCT07019532Not Yet Recruiting

Machine Learning-Based Risk Stratification for Fistula Formation After Perianal Abscess Drainage

NCT01793168Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT06184438Phase 4CompletedPrimary

Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery

Scroll to load more

Research Network

Activity Timeline